BioCentury
ARTICLE | Distillery Therapeutics

Therapeutics: MicroRNA-155 (miR-155); aryl hydrocarbon receptor nuclear translocator-like (ARNTL; BMAL1)

June 4, 2015 7:00 AM UTC

In vitro and mouse studies suggest inhibiting miR-155 could help reduce inflammation in sepsis. In mouse models of sepsis, zeitgeber time 12 (ZT12) - the transition to the active phase of the day - co...